- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17.04. | Glenmark Pharma's US arm set to launch generic Adderall tablets | 3 | capitalmarket.com | ||
| 16.04. | Glenmark To Launch Generic Adderall Tablets In May 2025 | 370 | AFX News | WASHINGTON (dpa-AFX) - Glenmark Pharmaceuticals Inc., USA, a wholly owned subsidiary of Glenmark Pharmaceuticals Limited (GLENMARK.NS) Wednesday announced its upcoming May 2025 launch of a generic... ► Artikel lesen | |
| 13.04. | Glenmark, Sun Pharma, Zydus Recall Medicines In US Over Manufacturing Issues | 3 | The Free Press Journal | ||
| 11.04. | Glenmark Pharmaceuticals Ltd slips for fifth straight session | 3 | capitalmarket.com | ||
| 01.04. | Glenmark Launches Vancomycin Hydrochloride For Injection In 3 Doses | 274 | AFX News | NEW DELHI (dpa-AFX) - Glenmark Pharmaceuticals Inc., USA, affiliated to India-based Glenmark Pharmaceuticals Ltd., announced Tuesday the launch of Vancomycin Hydrochloride for Injection USP... ► Artikel lesen | |
| 01.04. | Glenmark launches Vancomycin Hydrochloride for injection USP in the USA | 4 | capitalmarket.com | ||
| 25.03. | Glenmark Pharmaceuticals Ltd: Glenmark Pharmaceuticals Launches Pioneering Nutrition Program to Fight Malnutrition in the Philippines | 272 | PR Newswire | MANILA, Philippines, March 25, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Ltd. (Glenmark), a leading research-led, global pharmaceuticals company has partnered with, Health Futures Foundation... ► Artikel lesen | |
| GLENMARK PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 21.03. | Glenmark Pharma gains as arm gets USFDA nod for Olopatadine Ophthalmic solution | 3 | capitalmarket.com | ||
| 21.03. | Glenmark Gets FDA Approval For Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) | 382 | AFX News | NEW DELHI (dpa-AFX) - Glenmark Pharmaceuticals Inc., USA announced that it has received final approval from the U.S. Food & Drug Administration (FDA) for its Olopatadine Hydrochloride Ophthalmic... ► Artikel lesen | |
| 21.03. | Stock Alert: Hindustan Unilever, Hindalco Inds, Glenmark Pharma, Ashoka Buildcon | 5 | capitalmarket.com | ||
| 12.03. | Glenmark Pharma launches generic Empagliflozin in India | 4 | capitalmarket.com | ||
| 10.03. | Glenmark Pharma launches osmotic laxative Polyethylene Glycol in US | 2 | capitalmarket.com | ||
| 04.03. | Glenmark issues another recall, this time for nearly 1.5M bottles of generic ADHD drug | 10 | FiercePharma | ||
| 04.03. | Glenmark Pharma launches Acetylcysteine injection in US; long-term positive? | 6 | ZEE Business | ||
| 03.03. | Glenmark Acquires and Launches Acetylcysteine Injection | 2 | Contract Pharma | ||
| 03.03. | Glenmark Pharmaceuticals USA Buys, Launches Acetylcysteine Injection 6 Gm/30 ML Single-Dose Vials | 254 | AFX News | NEW DELHI (dpa-AFX) - Glenmark Pharmaceuticals Inc., USA announces the acquisition and launch of Acetylcysteine Injection, 6 gm/30 mL Single-Dose Vials. The company acquired the ANDA for Acetylcysteine... ► Artikel lesen | |
| 03.03. | Glenmark Pharmaceuticals Ltd: Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials | 138 | PR Newswire | MAHWAH, N.J., March 3, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the acquisition and launch1 of Acetylcysteine Injection,... ► Artikel lesen | |
| 03.03. | Glenmark Pharma gains after arm launches Acetylcysteine injection | 3 | capitalmarket.com | ||
| 03.03. | Glenmark shares in focus after recall of 15 lakh bottles of ADHD drug in US | 4 | Times of India | ||
| 03.03. | Stocks in news: M&M, Glenmark Pharma, Tata Motors, IOB, Sun Pharma | 4 | Times of India |
Seite:
1 2 3 4 Weiter >>
71 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SINOPHARM | 2,039 | +1,04 % | Sinopharm Group-Aktie kann Vortagsniveau nicht halten (2,006 €) | Am Aktienmarkt notiert die Sinopharm Group-Aktie gegenwärtig etwas leichter. Das Papier notiert zur Stunde bei 2,01 Euro. Für Inhaber der Sinopharm Group ist der heutige Handelstag bisher nicht sonderlich... ► Artikel lesen | |
| CSPC PHARMA | 0,686 | -3,08 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - SYH2068 INJECTION (A DOUBLE-STRANDED SMALL INTERFERING RNA DRUG) OBTAINS CLINICAL TRIAL APPROVAL | ||
| WUXI BIOLOGICS | 2,524 | -1,81 % | WuXi Biologics-Aktie heute am Aktienmarkt gefragt (2,665 €) | An der Börse notiert die Aktie von WuXi Biologics gegenwärtig fester. Das Wertpapier notiert zur Stunde bei 2,67 Euro. Jahreschart der WuXi Biologics Inc-Aktie, Stand 25.04.2025 Freuen können sich gegenwärtig... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 1,630 | -4,45 % | FOSUN PHARMA (02196): CONNECTED TRANSACTION - FORMATION OF PARTNERSHIP | ||
| DR REDDYS | 12,200 | 0,00 % | DR REDDYS LABORATORIES LTD - 6-K, Report of foreign issuer | ||
| GEDEON RICHTER | 27,060 | +0,89 % | Gedeon Richter Plc.: Extraordinary Information | ||
| ASPEN PHARMACARE | 5,650 | +0,89 % | ASPEN PHARMACARE HOLDINGS LIMITED - Potential Risks have Performance Implications for Manufacturing | ||
| SHANGHAI PHARMACEUTICALS | 1,220 | -2,40 % | SH PHARMA (02607): 2024 SUSTAINABILITY REPORT & ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,066 | -14,29 % | SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT - DAPAGLIFLOZIN TABLETS DEVELOPED BY HUISHENG BIOPHARMACEUTICAL OBTAINED DRUG REGISTRATION APPROVAL FROM ... | ||
| LUYE PHARMA | 0,222 | 0,00 % | LUYE PHARMA (02186): VOLUNTARY ANNOUNCEMENT ROTIGOTINE LUYE TRANSDERMAL PATCH LAUNCHED IN THE UNITED KINGDOM | ||
| CHINA RESOURCES PHARMACEUTICAL | 0,545 | -2,68 % | CHINARES PHARMA (03320): ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR BOYA BIO-PHARMACEUTICAL FOR THE THREE MONTHS ENDED 31 MARCH 2025 | ||
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 0,890 | 0,00 % | SHINEWAY PHARM (02877): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2024 ANNUAL REPORT, CIRCULAR, NOTICE OF THE ANNUAL ... | ||
| HANSOH PHARMACEUTICAL | 2,740 | 0,00 % | HANSOH PHARMA (03692): VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF HENGMEIDA (IBREXAFUNGERP TABLETS) WAS GRANTED BY THE NATIONAL MEDICAL PRODUCTS ... | ||
| KALBE FARMA | 0,059 | -1,67 % | KLBF potentially distribute 45% to 55% dividend for 2024: KLBF has the potential to distribute 45% to ... | ||
| YICHANG HEC CHANGJIANG PHARMACEUTICAL | - | - | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT MONTHLY UPDATE IN RELATION TO THE PROPOSED PRE-CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL ... |
GLENMARK PHARMACEUTICALS LIMITED gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLENMARK PHARMACEUTICALS LIMITED finden Sie auf Wallstreet Online.
